搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Burkholderia mallei 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP383519BPP
CSB-EP383519BPP
CSB-BP383519BPP
CSB-MP383519BPP
CSB-EP383519BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Cell division topological specificity factor (minE) CSB-YP383520BPP
CSB-EP383520BPP
CSB-BP383520BPP
CSB-MP383520BPP
CSB-EP383520BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Homogentisate 1,2-dioxygenase (hmgA) CSB-YP383521BPP
CSB-EP383521BPP
CSB-BP383521BPP
CSB-MP383521BPP
CSB-EP383521BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei UPF0301 protein BMA10229_A2746 (BMA10229_A2746) CSB-YP383522BPP
CSB-EP383522BPP
CSB-BP383522BPP
CSB-MP383522BPP
CSB-EP383522BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei 50S ribosomal protein L32 (rpmF) CSB-YP383523BPP
CSB-EP383523BPP
CSB-BP383523BPP
CSB-MP383523BPP
CSB-EP383523BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Elongation factor 4 (lepA), partial CSB-YP383524BPP
CSB-EP383524BPP
CSB-BP383524BPP
CSB-MP383524BPP
CSB-EP383524BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei N-succinylarginine dihydrolase (astB) CSB-YP383525BPP
CSB-EP383525BPP
CSB-BP383525BPP
CSB-MP383525BPP
CSB-EP383525BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP383526BPP1
CSB-EP383526BPP1
CSB-BP383526BPP1
CSB-MP383526BPP1
CSB-EP383526BPP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Deoxycytidine triphosphate deaminase (dcd) CSB-YP383527BPP
CSB-EP383527BPP
CSB-BP383527BPP
CSB-MP383527BPP
CSB-EP383527BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Probable Fe (2+)-trafficking protein CSB-YP383528BPP
CSB-EP383528BPP
CSB-BP383528BPP
CSB-MP383528BPP
CSB-EP383528BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Cysteine--tRNA ligase (cysS) CSB-YP383529BPP
CSB-EP383529BPP
CSB-BP383529BPP
CSB-MP383529BPP
CSB-EP383529BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Alanine racemase (alr) CSB-YP383530BPP
CSB-EP383530BPP
CSB-BP383530BPP
CSB-MP383530BPP
CSB-EP383530BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei [Protein-PII] uridylyltransferase (glnD), partial CSB-YP383531BPP
CSB-EP383531BPP
CSB-BP383531BPP
CSB-MP383531BPP
CSB-EP383531BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP383532BPP
CSB-EP383532BPP
CSB-BP383532BPP
CSB-MP383532BPP
CSB-EP383532BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei SsrA-binding protein (smpB) CSB-YP383533BPP
CSB-EP383533BPP
CSB-BP383533BPP
CSB-MP383533BPP
CSB-EP383533BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Large-conductance mechanosensitive channel (mscL), partial CSB-YP383534BPP1
CSB-EP383534BPP1
CSB-BP383534BPP1
CSB-MP383534BPP1
CSB-EP383534BPP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP383535BPP
CSB-EP383535BPP
CSB-BP383535BPP
CSB-MP383535BPP
CSB-EP383535BPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia mallei Probable intracellular septation protein A (BMA10229_A3372), partial CSB-YP383536BPP1
CSB-EP383536BPP1
CSB-BP383536BPP1
CSB-MP383536BPP1
CSB-EP383536BPP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP383537MNX
CSB-EP383537MNX
CSB-BP383537MNX
CSB-MP383537MNX
CSB-EP383537MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum ATP synthase subunit c (atpE), partial CSB-YP383538MNX1
CSB-EP383538MNX1
CSB-BP383538MNX1
CSB-MP383538MNX1
CSB-EP383538MNX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>